BluePath Capital Management
HIMS icon

BluePath Capital Management’s Hims & Hers Health HIMS Stock Holding History

BluePath Capital Management’s Portfolio HIMS Stock Details HIMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-58,864
Closed -$2.04M – 135
2026
Q2 		$2.04M Buy
58,864
+15,599
+36% +$419K 1.12% 16
2026
Q1 		$898K Buy
43,265
+17,397
+67% +$411K 0.62% 71
2025
Q4 		$840K Buy
25,868
+3,084
+14% +$132K 0.57% 73
2025
Q3 		$1.29M Buy
22,784
+1,951
+9% +$100K 0.95% 27
2025
Q2 		$1.04M Buy
20,833
+342
+2% +$15.5K 0.91% 31
2025
Q1 		$606K Buy
+20,491
New +$761K 0.63% 52

Other funds holding HIMS

State of Michigan Retirement System
State of Michigan Retirement System Lansing, Michigan $22.6B AUM 32.98% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
QV Investors
QV Investors Calgary, Alberta, Canada $1.36B AUM 20.86% 1-Year Est. Return
Lake Street Private Wealth
Lake Street Private Wealth Chicago, Illinois $908M AUM 20.93% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Udine Wealth Management
Udine Wealth Management Boca Raton, Florida $253M AUM 20.1% 1-Year Est. Return
Blue Jean Financial
Blue Jean Financial Albany, New York $163M AUM 49.58% 1-Year Est. Return
NLB Skladi upravljanje premozenja
NLB Skladi upravljanje premozenja Ljubljana $2.71B AUM 53.8% 1-Year Est. Return
Amalgamated Bank
Amalgamated Bank New York $14.3B AUM 35.81% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

BluePath Capital Management's HIMS Position: Q3 2026 in Review

BluePath Capital Management sold out of Hims & Hers Health (HIMS) in Q3 2026, closing a stake of 58,864 shares — an estimated $2.04M sold.

BluePath Capital Management first reported a position in HIMS in Q1 2025 and held it in 6 quarters. The position peaked at $2.04M in Q2 2026. 101 funds tracked by Wall St. Rank hold HIMS as of Q3 2026.

  • BluePath Capital Management reported no remaining Hims & Hers Health position as of Q3 2026 after selling out during the quarter.
  • BluePath Capital Management sold 58,864 Hims & Hers Health shares in Q3 2026, an estimated $2.04M.
  • BluePath Capital Management first reported a position in Hims & Hers Health in Q1 2025 and held it in 6 quarters.
  • BluePath Capital Management's Hims & Hers Health position peaked at $2.04M in Q2 2026.
  • 101 funds tracked by Wall St. Rank held Hims & Hers Health as of Q3 2026.

Based on BluePath Capital Management's 13F filing for Q3 2026, filed 26 Oct 2026.